Healthcare / Medical Care FacilitiesFrankfurt
$10.70
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $56.7M · quality 67.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$188M
P/E
14.3x
↓EV/EBITDA
3.5x
↓ROE
28.2%
↑Gross Margin
69.9%
↑Debt/Equity
0.78
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-15.7%
FCF CAGR
-7.1%
FCF margin
15.8%
FCF / Net income
1.90x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $254.2M · net income $21.3M · FCF $40.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $254.2M | $254.2M | $246.1M | $339.6M | $424.6M |
| Net Income | $21.3M | $21.3M | $73.5M | $18.5M | $-4.4M |
| EBITDA | $64.2M | $64.2M | $73.3M | $72.4M | $51.2M |
| EPS | 1.09 | 1.09 | 3.06 | 0.73 | -0.15 |
| Gross Margin | 69.9% | 69.9% | 70.4% | 64.6% | 66.1% |
| Operating Margin | 18.4% | 18.4% | 21.3% | 14.5% | 12.1% |
| Net Margin | 8.4% | 8.4% | 29.9% | 5.4% | -1.0% |
| Balance Sheet | |||||
| Debt/Equity | 0.78 | 0.78 | 0.61 | 1.36 | 1.81 |
| Current Ratio | 2.08 | 2.08 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $40.3M | $40.3M | $76.2M | $56.7M | $50.3M |
| Returns | |||||
| ROE | 28.2% | 28.2% | 60.2% | 21.5% | -5.6% |
| Valuation | |||||
| P/E | 14.27 | 14.27 | 3.37 | 8.56 | — |
| EV/EBITDA | 3.49 | 3.49 | 2.90 | 3.46 | 5.33 |
| P/B | 2.76 | 2.76 | 2.03 | 1.84 | 2.08 |
| Growth & Yield | |||||
| Revenue Growth | 3.3% | 3.3% | -27.5% | -20.0% | — |
| EPS Growth | -64.4% | -64.4% | 319.2% | 586.7% | — |
| Dividend Yield | 2.1% | 2.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-4.5%
EPS terminal req.
$0.95
Spread vs growth
-59.9%
5Y implied EPS CAGR
1.1%
EPS terminal req.
$1.15
Spread vs growth
-65.4%
10Y implied EPS CAGR
5.4%
EPS terminal req.
$1.85
Spread vs growth
-69.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+7.1%
Start / end P/E
3.3x → 9.6x
EPS bridge
3.06 → 1.09
Residual
-125.4%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.